Cargando…

Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment

Detalles Bibliográficos
Autores principales:	Renovanz, Mirjam, Kim, Ella L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050363/ https://www.ncbi.nlm.nih.gov/pubmed/24959421 http://dx.doi.org/10.3389/fonc.2014.00142

Ejemplares similares

Measuring Intratumoral Heterogeneity of Immune Repertoires
por: Yuzhakova, Diana Vladimirovna, et al.
Publicado: (2020)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma
por: Xu, Juan, et al.
Publicado: (2021)

Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
por: Brigliadori, Giovanni, et al.
Publicado: (2020)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
por: Lin, Zhen, et al.
Publicado: (2020)

Assessment of Intratumor Heterogeneity in Parametric Dynamic Contrast-Enhanced MR Images: A Comparative Study of Novel and Established Methods
por: Gaustad, Jon-Vidar, et al.
Publicado: (2021)

Review of Prevalence Studies of Tic Disorders: Methodological Caveats
por: Cubo, Esther
Publicado: (2012)

The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis
por: Bergmann, Natalie, et al.
Publicado: (2020)

Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution
por: Su, Narun, et al.
Publicado: (2022)

Improved risk stratification by PET-based intratumor heterogeneity in children with high-risk neuroblastoma
por: Li, Chao, et al.
Publicado: (2022)

Assessment Practice of Patient-Centered Outcomes in Surgical Neuro-Oncology: Survey-Based Recommendations for Clinical Routine
por: Weiss Lucas, Carolin, et al.
Publicado: (2021)

Intratumor Heterogeneity as a Prognostic Factor in Solid Tumors: A Systematic Review and Meta-Analysis
por: Yu, Tao, et al.
Publicado: (2021)

Intratumor Heterogeneity and Therapy Resistance: Contributions of Dormancy, Apoptosis Reversal (Anastasis) and Cell Fusion to Disease Recurrence
por: Mirzayans, Razmik, et al.
Publicado: (2020)

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives
por: Romano, Alessandra, et al.
Publicado: (2019)

The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
por: Nicoś, Marcin, et al.
Publicado: (2020)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
por: Qiu, Yuan, et al.
Publicado: (2022)

Assessment and Prognostic Value of Immediate Changes in Post-Ablation Intratumor Density Heterogeneity of Pulmonary Tumors via Radiomics-Based Computed Tomography Features
por: Liu, Bo, et al.
Publicado: (2021)

Caveat lector
por: Eldawlatly, Abdelazeem, et al.
Publicado: (2012)

Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy
por: Qin, Yu, et al.
Publicado: (2021)

Research on the ecology of ticks and tick-borne pathogens—methodological principles and caveats
por: Estrada-Peña, Agustín, et al.
Publicado: (2013)

A caveat concerning center of resistance
por: Dathe, Henning, et al.
Publicado: (2013)

Intratumoral microbiome and gastrointestinal cancers
por: Li, Shengnan, et al.
Publicado: (2022)

Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
por: Lin, Peng-Chan, et al.
Publicado: (2020)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Caveat emptor
por: Aswani, Yashant, et al.
Publicado: (2015)

Caveats for Dispensers
Publicado: (1921)

Caveat creator
por: Fuisz, Richard
Publicado: (2018)

Caveat scriptor
por: Loadsman, John A.
Publicado: (2018)

Caveats for Dispensers
Publicado: (1921)

A Time-Based and Intratumoral Proteomic Assessment of a Recurrent Glioblastoma Multiforme
por: de Aquino, Priscila F., et al.
Publicado: (2016)

Methodological Caveats in the Detection of Coordinated Replay between Place Cells and Grid Cells
por: Trimper, John B., et al.
Publicado: (2017)

Intratumoral heterogeneity impacts the response to anti-neu antibody therapy
por: Song, Hyunkeun, et al.
Publicado: (2014)

Assessment of intratumoral heterogeneity with mutations and gene expression profiles
por: Sung, Ji-Yong, et al.
Publicado: (2019)

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
por: Zilenaite, Dovile, et al.
Publicado: (2020)

Predictive value of intratumoral-metabolic heterogeneity derived from (18)F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
por: Zhang, Li, et al.
Publicado: (2023)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Evolutionary Dynamics of Intratumor Heterogeneity
por: Iwasa, Yoh, et al.
Publicado: (2011)

Intratumor and Intertumor Heterogeneity in Melanoma
por: Grzywa, Tomasz M., et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qoqnsn7e8eo9r0i8bk70thh83d